Longjam L, Tsering D, Das D
J Lab Physicians. 2022; 14(2):169-174.
PMID: 35982877
PMC: 9381315.
DOI: 10.1055/s-0041-1735583.
Liu B, Li S, Li H, Wang X, Tan H, Liu S
J Int Med Res. 2020; 48(4):300060520910917.
PMID: 32339001
PMC: 7218464.
DOI: 10.1177/0300060520910917.
Tang J, Zhu H, Cai L, Tang T, Tang J, Sun Y
Infect Dis Poverty. 2018; 7(1):33.
PMID: 29631621
PMC: 5890356.
DOI: 10.1186/s40249-018-0408-5.
Tucker H, Wible M, Gandhi A, Quintana A
Infect Drug Resist. 2017; 10:401-417.
PMID: 29138583
PMC: 5679678.
DOI: 10.2147/IDR.S143306.
Ning N, Liu X, Bao C, Chen S, Cui E, Zhang J
BMC Infect Dis. 2017; 17(1):14.
PMID: 28056839
PMC: 5217423.
DOI: 10.1186/s12879-016-2110-1.
Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital ICU.
Nwadike V, Ojide C, Kalu E
Afr J Infect Dis. 2014; 8(1):14-8.
PMID: 24653812
PMC: 3957209.
Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals.
Maleki M, Sekawi Z, Soroush S, Azizi-Jalilian F, Asadollahi K, Mohammadi S
Iran J Basic Med Sci. 2014; 17(1):21-6.
PMID: 24592303
PMC: 3938882.
Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline.
Tas T, Kocoglu E, Mengeloglu Z, Bucak O, Karabork S
Bosn J Basic Med Sci. 2013; 13(4):266-70.
PMID: 24289764
PMC: 4334001.
DOI: 10.17305/bjbms.2013.2338.
Multidrug resistant acinetobacter.
Manchanda V, Sanchaita S, Singh N
J Glob Infect Dis. 2010; 2(3):291-304.
PMID: 20927292
PMC: 2946687.
DOI: 10.4103/0974-777X.68538.
Detection of KPC in Acinetobacter spp. in Puerto Rico.
Robledo I, Aquino E, Sante M, Santana J, Otero D, Leon C
Antimicrob Agents Chemother. 2009; 54(3):1354-7.
PMID: 20038618
PMC: 2825984.
DOI: 10.1128/AAC.00899-09.
Acinetobacter baumannii: emergence of a successful pathogen.
Peleg A, Seifert H, Paterson D
Clin Microbiol Rev. 2008; 21(3):538-82.
PMID: 18625687
PMC: 2493088.
DOI: 10.1128/CMR.00058-07.
Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California.
Valentine S, Contreras D, Tan S, Real L, Chu S, Xu H
J Clin Microbiol. 2008; 46(8):2499-507.
PMID: 18524965
PMC: 2519477.
DOI: 10.1128/JCM.00367-08.
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
Karageorgopoulos D, Kelesidis T, Kelesidis I, Falagas M
J Antimicrob Chemother. 2008; 62(1):45-55.
PMID: 18436554
PMC: 8057304.
DOI: 10.1093/jac/dkn165.
Treatment options for multidrug-resistant Acinetobacter species.
Gilad J, Carmeli Y
Drugs. 2008; 68(2):165-89.
PMID: 18197724
DOI: 10.2165/00003495-200868020-00003.
